Difference between revisions of "Part:BBa K511203:Design"
(→Source) |
|||
| Line 1: | Line 1: | ||
| − | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K511203 short</partinfo> | <partinfo>BBa_K511203 short</partinfo> | ||
| Line 13: | Line 12: | ||
===Source=== | ===Source=== | ||
| − | This protein is a heavily engineered fusion between the tetracycline operator binding domain from TetR and the viral VP16 transactivation domain from the herpes simplex virus. | + | This protein is a heavily engineered fusion between the tetracycline operator binding domain from TetR and the viral VP16 transactivation domain from the herpes simplex virus. Sincere thanks go to the Weiss lab for contributing this entry vector to the MIT iGEM 2011 team. |
===References=== | ===References=== | ||
Latest revision as of 01:05, 21 October 2011
rtTA3 Tetracycline-Inducible Transactivator MammoBlock
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
Not applicable.
Source
This protein is a heavily engineered fusion between the tetracycline operator binding domain from TetR and the viral VP16 transactivation domain from the herpes simplex virus. Sincere thanks go to the Weiss lab for contributing this entry vector to the MIT iGEM 2011 team.